OWPC
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Sep 4 closing price
Capitalization
4.39M
RAFA
Price
$0.09
Change
+$0.01 (+12.50%)
Updated
Sep 3 closing price
Capitalization
8.17M
Interact to see
Advertisement

OWPC vs RAFA

Header iconOWPC vs RAFA Comparison
Open Charts OWPC vs RAFABanner chart's image
One World Products
Price$0.04
Change-$0.00 (-0.00%)
Volume$65.52K
Capitalization4.39M
Rafarma Pharmaceuticals, Inc. (WY)
Price$0.09
Change+$0.01 (+12.50%)
Volume$25.5K
Capitalization8.17M
OWPC vs RAFA Comparison Chart in %
Loading...
OWPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OWPC vs. RAFA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OWPC is a Buy and RAFA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (OWPC: $0.04 vs. RAFA: $0.09)
Brand notoriety: OWPC and RAFA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OWPC: 36% vs. RAFA: 64%
Market capitalization -- OWPC: $4.39M vs. RAFA: $8.17M
OWPC [@Pharmaceuticals: Generic] is valued at $4.39M. RAFA’s [@Pharmaceuticals: Generic] market capitalization is $8.17M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OWPC’s FA Score shows that 0 FA rating(s) are green whileRAFA’s FA Score has 2 green FA rating(s).

  • OWPC’s FA Score: 0 green, 5 red.
  • RAFA’s FA Score: 2 green, 3 red.
According to our system of comparison, RAFA is a better buy in the long-term than OWPC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OWPC’s TA Score shows that 7 TA indicator(s) are bullish while RAFA’s TA Score has 6 bullish TA indicator(s).

  • OWPC’s TA Score: 7 bullish, 4 bearish.
  • RAFA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both OWPC and RAFA are a good buy in the short-term.

Price Growth

OWPC (@Pharmaceuticals: Generic) experienced а +37.93% price change this week, while RAFA (@Pharmaceuticals: Generic) price change was +42.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.80%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +86.08%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.80% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAFA($8.17M) has a higher market cap than OWPC($4.39M). OWPC YTD gains are higher at: 65.975 vs. RAFA (20.440).
OWPCRAFAOWPC / RAFA
Capitalization4.39M8.17M54%
EBITDA-4.79MN/A-
Gain YTD65.97520.440323%
P/E RatioN/AN/A-
Revenue2.56KN/A-
Total Cash81.6KN/A-
Total Debt3.49MN/A-
FUNDAMENTALS RATINGS
OWPC vs RAFA: Fundamental Ratings
OWPC
RAFA
OUTLOOK RATING
1..100
1515
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1003
PRICE GROWTH RATING
1..100
3539
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OWPC's Valuation (37) in the null industry is somewhat better than the same rating for RAFA (71). This means that OWPC’s stock grew somewhat faster than RAFA’s over the last 12 months.

OWPC's Profit vs Risk Rating (100) in the null industry is in the same range as RAFA (100). This means that OWPC’s stock grew similarly to RAFA’s over the last 12 months.

RAFA's SMR Rating (3) in the null industry is significantly better than the same rating for OWPC (100). This means that RAFA’s stock grew significantly faster than OWPC’s over the last 12 months.

OWPC's Price Growth Rating (35) in the null industry is in the same range as RAFA (39). This means that OWPC’s stock grew similarly to RAFA’s over the last 12 months.

RAFA's P/E Growth Rating (2) in the null industry is significantly better than the same rating for OWPC (100). This means that RAFA’s stock grew significantly faster than OWPC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OWPCRAFA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 23 days ago
88%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
OWPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUHU6.070.01
+0.17%
HUHUTECH International Group Inc
TEVA18.48-0.28
-1.49%
Teva Pharmaceutical Industries Limited
CSIQ9.71-0.19
-1.92%
Canadian Solar
TLX9.08-0.28
-2.99%
Telix Pharmaceuticals Ltd.
WATT6.76-0.42
-5.85%
Energous Corporation

OWPC and

Correlation & Price change

A.I.dvisor tells us that OWPC and OMID have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OWPC and OMID's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OWPC
1D Price
Change %
OWPC100%
+0.25%
OMID - OWPC
10%
Poorly correlated
N/A
PCLOF - OWPC
8%
Poorly correlated
+21.87%
RAFA - OWPC
7%
Poorly correlated
N/A
RGEDF - OWPC
4%
Poorly correlated
+7.64%
OILFF - OWPC
-1%
Poorly correlated
N/A
More